Literature DB >> 18852687

Spatial and temporal clustering of Kawasaki syndrome cases.

Annie S Kao1, Arthur Getis, Stephanie Brodine, Jane C Burns.   

Abstract

BACKGROUND: The etiology of Kawasaki syndrome (KS) remains unknown despite 30 years of intensive search for an agent. Epidemiologic clues to a possible infectious etiology include the seasonal distribution of cases, the previous occurrence of epidemics, the clinical features of the syndrome that mimic other infectious rash/fever illnesses in children, the self-limited nature of the illness, and the peak age incidence in the toddler years.
METHODS: We examined the epidemiology and spatial and temporal distribution of KS cases in San Diego County, California during the 6-year period from 1998 to 2003. Clustering in space and time was analyzed using geo-referenced data with the K-function, the local G-statistic, and Knox statistic.
RESULTS: A total of 318 patients were identified through active surveillance. The overall annual incidence was 21.7/100,000 in children <5 years, with rates in whites, white Hispanics, and Asian/Pacific Islanders of 15.3, 20.2, and 45.9/100,000, respectively. The Knox test showed significant clustering of cases within the space-time interval of 3 km and 3-5 days.
CONCLUSIONS: This is the first study of KS cases to use geo-referenced point pattern analysis to detect spatial and temporal clustering of KS cases. These data suggest that an infectious agent triggers the immunologic cascade of KS.

Entities:  

Mesh:

Year:  2008        PMID: 18852687      PMCID: PMC2870532          DOI: 10.1097/INF.0b013e31817acf4f

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  14 in total

Review 1.  Finding the cause of Kawasaki disease: a pediatric infectious diseases research priority.

Authors:  Anne H Rowley
Journal:  J Infect Dis       Date:  2006-11-02       Impact factor: 5.226

2.  IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease.

Authors:  A H Rowley; S T Shulman; C A Mask; L S Finn; M Terai; S C Baker; C A Galliani; K Takahashi; S Naoe; M B Kalelkar; S E Crawford
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

3.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

4.  Seasonality and temporal clustering of Kawasaki syndrome.

Authors:  Jane C Burns; Daniel R Cayan; Garrick Tong; Emelia V Bainto; Christena L Turner; Hiroko Shike; Tomisaku Kawasaki; Yosikazu Nakamura; Mayumi Yashiro; Hiroshi Yanagawa
Journal:  Epidemiology       Date:  2005-03       Impact factor: 4.822

5.  A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.

Authors:  J W Newburger; M Takahashi; A S Beiser; J C Burns; J Bastian; K J Chung; S D Colan; C E Duffy; D R Fulton; M P Glode
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

6.  Kawasaki syndrome in Hawaii.

Authors:  Robert C Holman; Aaron T Curns; Ermias D Belay; Claudia A Steiner; Paul V Effler; Krista L Yorita; Jill Miyamura; Susan Forbes; Lawrence B Schonberger; Marian Melish
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

7.  Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody.

Authors:  Anne H Rowley; Susan C Baker; Stanford T Shulman; Francesca L Garcia; Judith A Guzman-Cottrill; Pauline Chou; Masaru Terai; Tomisaku Kawasaki; Mitra B Kalelkar; Susan E Crawford
Journal:  J Infect Dis       Date:  2004-07-16       Impact factor: 5.226

8.  Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in children with Kawasaki syndrome.

Authors:  Matthew S Wilder; Lawrence A Palinkas; Annie S Kao; John F Bastian; Christena L Turner; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2007-03       Impact factor: 2.129

9.  Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003.

Authors:  Ermias D Belay; Ryan A Maddox; Robert C Holman; Aaron T Curns; Konique Ballah; Lawrence B Schonberger
Journal:  Pediatr Infect Dis J       Date:  2006-03       Impact factor: 2.129

10.  Kawasaki syndrome: description of two outbreaks in the United States.

Authors:  D M Bell; E W Brink; J L Nitzkin; C B Hall; H Wulff; I D Berkowitz; P M Feorino; R C Holman; C L Huntley; R H Meade; L J Anderson; S H Cheeseman; N J Fiumara; R F Gilfillan; D E Keim; J F Modlin
Journal:  N Engl J Med       Date:  1981-06-25       Impact factor: 91.245

View more
  22 in total

1.  Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia.

Authors:  Lori B Daniels; Matthew S Tjajadi; Hannah H Walford; Susan Jimenez-Fernandez; Vera Trofimenko; Daryl B Fick; Hoang-Anh L Phan; Peter E Linz; Keshav Nayak; Andrew M Kahn; Jane C Burns; John B Gordon
Journal:  Circulation       Date:  2012-05-17       Impact factor: 29.690

2.  National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA.

Authors:  Yusuke Okubo; Kotaro Nochioka; Hiroshi Sakakibara; Marcia Testa; Robert P Sundel
Journal:  Clin Rheumatol       Date:  2016-12-16       Impact factor: 2.980

Review 3.  Treatment Options for Resistant Kawasaki Disease.

Authors:  Linny Kimly Phuong; Nigel Curtis; Peter Gowdie; Jonathan Akikusa; David Burgner
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

4.  Recurrent fever syndromes in patients after recovery from Kawasaki syndrome.

Authors:  Lori Broderick; Adriana H Tremoulet; Jane C Burns; John F Bastian; Hal M Hoffman
Journal:  Pediatrics       Date:  2011-01-10       Impact factor: 7.124

5.  Health care utilization and costs following Kawasaki disease.

Authors:  Cal Robinson; Rahul Chanchlani; Anastasia Gayowsky; Elizabeth Darling; Hsien Seow; Michelle Batthish
Journal:  Paediatr Child Health       Date:  2022-03-01       Impact factor: 2.600

Review 6.  Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome.

Authors:  M A Bordea; C Costache; A Grama; A I Florian; I Lupan; G Samasca; D Deleanu; P Makovicky; P Makovicky; K Rimarova
Journal:  Physiol Res       Date:  2022-01-19       Impact factor: 1.881

7.  SARS-CoV-2 infection triggering recurrence of Kawasaki disease in a 10-year-old child.

Authors:  Ashok Renganathan; Ankit Garg; Sona Chowdhary; Dinesh Raj
Journal:  BMJ Case Rep       Date:  2021-03-24

8.  Association of Kawasaki disease with tropospheric wind patterns.

Authors:  Xavier Rodó; Joan Ballester; Dan Cayan; Marian E Melish; Yoshikazu Nakamura; Ritei Uehara; Jane C Burns
Journal:  Sci Rep       Date:  2011-11-10       Impact factor: 4.379

9.  Finding Kawasaki disease.

Authors:  Jane C Burns
Journal:  Ann Pediatr Cardiol       Date:  2012-07

10.  Decreasing fertility rate correlates with the chronological increase and geographical variation in incidence of Kawasaki disease in Japan.

Authors:  Yoshiro Nagao
Journal:  PLoS One       Date:  2013-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.